Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes

Type 1 diabetes (T1D) is an autoimmune proinflammatory disease with no effective intervention. A major obstacle in developing new immunotherapies for T1D is the lack of means for monitoring immune responsiveness to experimental therapies. The LEW1.WR1 rat develops autoimmunity following infection wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Needell, James C., Dinarello, Charles A., Ir, Diana, Robertson, Charles E., Ryan, Sarah M., Kroehl, Miranda E., Frank, Daniel N., Zipris, Danny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354421/
https://www.ncbi.nlm.nih.gov/pubmed/28301545
http://dx.doi.org/10.1371/journal.pone.0173968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354421/
https://www.ncbi.nlm.nih.gov/pubmed/28301545
http://dx.doi.org/10.1371/journal.pone.0173968

Ejemplares similares